period,total_demand,total_supply,shortage_amount,unsold,shortage_percentage,disrupted_manufacturers,fda_announcement
0,1.2,0.9,0.29999999999999993,0.0,0.24999999999999994,[1],
1,1.5,0.9,0.6,0.0,0.39999999999999997,[1],The FDA is closely monitoring the emerging shortage situation. We encourage manufacturers to report any disruptions and collaborate to ensure supply stability.
2,1.3,1.05,0.25,0.050000000000000044,0.1923076923076923,[1],The FDA is aware of an emerging shortage in the market and is actively monitoring the situation. We encourage manufacturers to report any disruptions and coordinate to address supply issues. Patient safety remains our priority.
3,1.5,1.05,0.44999999999999996,0.050000000000000044,0.3,[1],The FDA is issuing a shortage alert for the affected drug due to emerging supply disruptions. We encourage manufacturers to increase production capacity where possible and urge stakeholders to coordinate effectively to mitigate impact. Healthcare providers should monitor inventory levels and prioritize critical needs.
4,1.5,1.165,0.33499999999999996,0.16500000000000004,0.2233333333333333,[1],The FDA is aware of an emerging shortage and is actively coordinating with manufacturers to address supply disruptions. Stakeholders are encouraged to report supply issues and collaborate on solutions.
5,1.2,1.2,0.0,0.19999999999999996,0.0,[1],The FDA is aware of emerging supply disruptions affecting certain medications. We are actively monitoring the situation and encourage manufacturers to report any production issues. Stakeholders are advised to maintain normal purchasing patterns to avoid exacerbating the situation.
6,1.2,1.2,0.0,0.19999999999999996,0.0,[1],The FDA is aware of emerging disruptions in the supply of certain drugs. We encourage manufacturers to report any anticipated shortages and are monitoring the situation closely to facilitate coordination.
7,1.1,1.1,0.0,0.10000000000000009,0.0,[1],The FDA is closely monitoring the emerging supply disruptions in the market. We encourage manufacturers to report any production issues and buyers to maintain normal purchasing patterns to prevent exacerbating the situation.
